Bharat Immunologicals & Biologicals Corporation Ltd.

Financial

	Bharat Immunological	Makers Laboratories	Ind-Swift
Operational Metrics
Financials
5 yr Average ROE	-29.83 %	0.31 %	13.04 %
5yr average Equity Multiplier	3.08	2.36	-0.95
5yr Average Asset Turnover Ratio	0.61	0.7	0.57
5yr Avg Net Profit Margin	-18.38 %	-0.21 %	-31.25 %
Price to Book	1.21	1.3	0.0
P/E	0.0	12.23	0.32
5yr Avg Cash Conversion Cycle	206.63 Days	75.08 Days	-141.81 Days
Inventory Days	125.06 Days	107.1 Days	64.0 Days
Days Receivable	61.4 Days	71.83 Days	88.62 Days
Days Payable	117.81 Days	106.28 Days	283.86 Days
5yr Average Interest Coverage Ratio	-2.32	4.73	-4.31
5yr Avg ROCE	-44.64 %	6.35 %	-53.05 %
5yr Avg Operating Profit Margin	-18.7 %	7.59 %	1.75 %
5 yr average Debt to Equity	0.71	0.21	-1.52
5yr CAGR Net Profit	23.51 %	n/a	n/a
5yr Average Return on Assets	-10.1 %	0.25 %	-12.25 %
Shareholdings
Promoter Holding	59.25 %	61.27 %	55.58 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Bharat Immunological	Makers Laboratories	Ind-Swift
Product Wise Break-Up	Product Wise Break-Up Oral Polio Vaccine 100.0 BIBSANIT 0 BIB VIT 0 Zinc Tablets 0 Services 0 Chemicals 0 Generic Formulation 0 Sales of APIs 0	Product Wise Break-Up Zinc Tablets 0 BIB VIT 0 Sales of APIs 0 Services 6.85 Formulation 28.7 Chemicals 63.85 BIBSANIT 0 Oral Polio Vaccine 0 Others 0.6	Product Wise Break-Up Zinc Tablets 0 BIB VIT 0 Active Pharmaceutical Ingredient (API) 100.0 Services 0 Generic Formulation 0 Chemicals 0 BIBSANIT 0 Oral Polio Vaccine 0
Asset Break-Up	Asset Break-Up Oral Polio Vaccine 94.18 Zinc Tablets 0.04 BIB sweets Tablets 0 Chemicals 0 Pharmaceuticals 0 Others 5.78	Asset Break-Up BIB sweets Tablets 0 Chemicals 66.91 Pharmaceuticals 33.09 Zinc Tablets 0 Oral Polio Vaccine 0	-